Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29528181

Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2018 Jul
First author
Dvorak CC

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Dvorak CC
      type
      Author
    2. name
      Satwani P
      type
      Author
    3. name
      Stieglitz E
      type
      Author
    4. name
      Cairo MS
      type
      Author
    5. name
      Dang H
      type
      Author
    6. name
      Pei Q
      type
      Author
    7. name
      Gao Y
      type
      Author
    8. name
      Wall D
      type
      Author
    9. name
      Mazor T
      type
      Author
    10. name
      Olshen AB
      type
      Author
    11. name
      Parker JS
      type
      Author
    12. name
      Kahwash S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Dvorak CC
      type
      Author
    2. name
      Satwani P
      type
      Author
    3. name
      Stieglitz E
      type
      Author
    4. name
      Cairo MS
      type
      Author
    5. name
      Dang H
      type
      Author
    6. name
      Pei Q
      type
      Author
    7. name
      Gao Y
      type
      Author
    8. name
      Wall D
      type
      Author
    9. name
      Mazor T
      type
      Author
    10. name
      Olshen AB
      type
      Author
    11. name
      Parker JS
      type
      Author
    12. name
      Kahwash S
      type
      Author
    bibliography ids
    1. nci-bib-c51d2f31ecdb7d692a969f56
    book metadata
    content sha256
    cad2de70c34ed623a17f1e994172f88e547b5d794144b795a3e3355efe55b8e9
    document type
    citation
    dois
    1. 10.1002/pbc.27034
    electronic publication date
    display
    2018 Mar 12
    precision
    day
    year
    2018
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29528181
    immutable id
    pubmed:29528181@cad2de70c34ed623a17f1e994172f88e547b5d794144b795a3e3355efe55b8e9
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    7
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e27034
    volume
    65
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29528181
      provenance
      batch id
      ec9444d0f4cade22eb9f
      provider
      NCBI PubMed ESummary
      record sha256
      e5438393fb8f8bb1eaae084794aee77041140690f1d4684a187bbad8c8c02e84
      response sha256
      6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
      retrieved at
      2026-09-09T23:47:30.975610+00:00
      publication date
      display
      2018 Jul
      precision
      month
      year
      2018
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Randomized Controlled Trial
      4. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29528181/
      title
      Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.

      Preserved source evidence · Not medical advice